ClinicalTrials.gg
Sign In

Muscular Dystrophy, Facioscapulohumeral clinical trials

The registry lists 79 studies for Muscular Dystrophy, Facioscapulohumeral across more than 10 countries. 26 are recruiting or about to start. 60 of them are mainly about Muscular Dystrophy, Facioscapulohumeral (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Muscular Dystrophy, Facioscapulohumeral studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
40
Recruiting
19
Active, not recruiting
7
Terminated
5
Enrolling by invitation
4
Not yet recruiting
3

Phase

Phase 2
19
Phase 1
13
Phase 3
2

Where

United States
32
France
19
Italy
13
Canada
12
Netherlands
11
United Kingdom
10

Who runs them

Centre Hospitalier Universitaire de Nice (8) · aTyr Pharma, Inc. (5) · Avidity Biosciences, Inc. (3) · LMU Klinikum (3) · University of Kansas Medical Center (3) · Fulcrum Therapeutics (3) · University of Rochester (3) · Grete Andersen, MD (2)

What is being tested here

Drugs under test in Muscular Dystrophy, Facioscapulohumeral studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
AOC 1020113
Apitegromab101
Clenbuterol101
ATYR-1940005
Losmapimod013
Efmitermant alfa002
Emugrobart001
Testosterone enanthate001
Testosterone001
Human Growth Hormone001

Coming up

1phase 3 study under way
8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Who these studies take

Of the 19 Muscular Dystrophy, Facioscapulohumeral studies recruiting now, 9 (47%) set no upper age limit and 9 (47%) stop at 75 or younger. 10 (53%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 6 (32%) take healthy volunteers.

Recruiting studies that take each age, of 19
AgeWomenMen
108 (42%)8 (42%)
1818 (95%)18 (95%)
3018 (95%)18 (95%)
4018 (95%)18 (95%)
5018 (95%)18 (95%)
6516 (84%)16 (84%)
7512 (63%)12 (63%)
859 (47%)9 (47%)

Across all 79 studies, recruiting or not: 56% stop at 75 or younger and 35% at 65; 30% take children; 0% are for women only and 1% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Muscular Dystrophy, Facioscapulohumeral studies take

Of 19 interventional studies with no phase under Muscular Dystrophy, Facioscapulohumeral, half reached primary completion within 21 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase21 mo13–39 · 19 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 79. Browse all 79 → or search them.